27.01.2015 Views

Guidelines for second generation HIV surveillance - World Health ...

Guidelines for second generation HIV surveillance - World Health ...

Guidelines for second generation HIV surveillance - World Health ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Trends among young people or recent initiators (of higher risk behaviours)<br />

<strong>HIV</strong> prevalence among young people (15–24 years) has been considered a proxy <strong>for</strong> incidence in generalized<br />

epidemics. Most young people have recently become sexually active and thus have been recently exposed to<br />

<strong>HIV</strong>. Infections among this population are likely to be relatively recent. This approach has been recommended<br />

in the guidelines <strong>for</strong> monitoring the UNGASS indicators (25). Some studies show that this is a good proxy <strong>for</strong><br />

trends among the general population (23).<br />

Similarly, new entrants to sex work, new users of injection drugs, or men who have recently started having<br />

anal sex are considered newly exposed to <strong>HIV</strong> and can be a proxy <strong>for</strong> <strong>HIV</strong> incidence in this population.<br />

Strengths: In generalized epidemics with existing ANC <strong>surveillance</strong> systems, changes in <strong>HIV</strong> prevalence<br />

among young pregnant women aged 15–24 years can be easily computed from existing data. For recent<br />

initiators of risk behaviours, most surveys or data collection <strong>for</strong>ms already collect in<strong>for</strong>mation on when they<br />

started the behaviour at increased risk, allowing the calculation of this trend line.<br />

Evaluating a National Surveillance System<br />

Weaknesses: These data may not be representative of the whole country due to any of the following reasons.<br />

• Urban settings may be overrepresented.<br />

• PMTCT implementing programmes may introduce new biases because they are limited to women. Men<br />

are not represented.<br />

• Pregnant <strong>HIV</strong>-infected women may “avoid” PMTCT programmes due to stigma, discrimination or other<br />

local issues when communities are small.<br />

• The use of antiretroviral therapy may affect <strong>HIV</strong> prevalence because many women who are <strong>HIV</strong>-positive<br />

and taking antiretroviral therapy have higher fertility.<br />

• When using data on recent initiators, the sample size may be too small to draw definite conclusions.<br />

In a recent paper, thirty countries most affected by <strong>HIV</strong> analysed trends in <strong>HIV</strong> prevalence among young ANC<br />

attendees using sites that were consistently included in <strong>surveillance</strong> between 2000 and 2008. Regression<br />

analysis was used to fit curves to the trend data and to determine if the 2001 United Nations Declaration<br />

of Commitment goal of 25% reduction in <strong>HIV</strong> prevalence had been reached. Seven countries showed a<br />

significant decline of 25% or more in <strong>HIV</strong> prevalence among young women attending ANC by 2008, either<br />

in rural areas, urban areas or both. In all seven countries that showed a significant decline in prevalence,<br />

marked changes were also observed in either men or women <strong>for</strong> at least two of the three sexual behavioural<br />

indicators (26).<br />

National population-based surveys<br />

Repeated cross-sectional measures of <strong>HIV</strong> prevalence are now becoming available <strong>for</strong> general populations in<br />

many countries. Hallet et al. have developed a mathematical approach to derive and estimate <strong>HIV</strong> incidence<br />

using demographic accounting methods. This method considers the change in <strong>HIV</strong> prevalence in a cohort<br />

observed over two time periods, and calculates the number new infections after adjusting <strong>for</strong> potential<br />

mortality during the time period (27).<br />

Strengths: Multiple surveys are available in a number of high-prevalence countries. The results can provide<br />

age-specific incidence estimates <strong>for</strong> men and women in urban and rural settings. If the sample size is large<br />

enough, the analysis can be done at a regional level.<br />

Weaknesses: <strong>HIV</strong> testing must be included in more than one national survey. This approach to <strong>HIV</strong><br />

<strong>surveillance</strong> should only be used in countries with generalized epidemics and only once every five years.<br />

Spectrum computer package<br />

This package developed by the Joint United Nations Programme on <strong>HIV</strong>/AIDS (UNAIDS) uses observed <strong>HIV</strong><br />

prevalence points over time to fit a prevalence curve. The prevalence curve can be used to back-calculate<br />

<strong>HIV</strong> incidence using the year the epidemic started in the country, the population size, mortality and the<br />

number of people on antiretroviral therapy.<br />

Strengths: Spectrum uses curve-fitting, which removes some of the instability of individual data points.<br />

Spectrum is used by most developing countries to estimate their national prevalence.<br />

45

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!